Valuation: Omnicell, Inc.

Market Cap 1.68B 1.45B 1.36B 1.24B 2.34B 160B 2.38B 15.91B 6.25B 80.1B 6.31B 6.17B 265B P/E 2026 *
37.4x
P/E 2027 * 36.3x
Enterprise Value 1.68B 1.45B 1.36B 1.24B 2.34B 160B 2.38B 15.91B 6.25B 80.1B 6.31B 6.17B 265B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.3x
Free-Float
76.33%
Yield 2026 *
-
Yield 2027 * -
1 day+1.80%
1 week+4.07%
Current month+4.07%
1 month-17.02%
3 months-15.05%
6 months-0.70%
Current year-18.74%
1 week 34.86
Extreme 34.86
38
1 month 34.86
Extreme 34.86
48.06
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/4/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+4.07%+18.63%-43.60% 1.68B
+5.82%+13.10%-17.62%+17.10% 37.44B
-1.07%+8.55%-44.95%+147.90% 12.99B
+1.06%+0.07%-24.59%+63.05% 5.44B
+5.99%+14.23% - - 2.49B
+3.31%+2.50% - - 1.84B
+0.08%-2.57%-36.05% - 1.02B
+1.98%+6.68%+36.18%+120.48% 915M
-1.36%+1.68%-37.84%-46.77% 833M
-5.16%+10.94%+617.07%+880.00% 768M
Average +1.24%+5.84%+63.85%+162.59% 6.54B
Weighted average by Cap. +3.52%+10.11%-14.86%+59.57%

Financials

2026 *2027 *
Net sales 1.24B 1.07B 999M 917M 1.72B 118B 1.75B 11.72B 4.6B 59B 4.64B 4.54B 195B 1.29B 1.11B 1.04B 955M 1.8B 123B 1.82B 12.21B 4.79B 61.45B 4.84B 4.73B 203B
Net income 45.27M 39.16M 36.57M 33.55M 63.1M 4.31B 64.1M 429M 168M 2.16B 170M 166M 7.14B 47.37M 40.97M 38.26M 35.1M 66.02M 4.51B 67.07M 449M 176M 2.26B 178M 174M 7.47B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
07/08/26 US$36.81 +1.80% 754,895
06/08/26 US$36.16 -2.72% 503,213
05/08/26 US$37.17 +0.05% 699,654
04/08/26 US$37.15 -1.33% 1,200,575
03/08/26 US$37.65 +6.45% 1,112,295
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
36.81USD
Average target price
57.86USD
Spread / Average Target
+57.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock